#Japan #Tokyo #Central Medience #GENOVA #Medical Doc

GENOVA Expands Healthcare Reach with Strategic Acquisition

On September 11, 2026, during a board meeting, GENOVA, headquartered in Shibuya, Tokyo, announced its decision to acquire the health media business 'Karada ni Ii Koto' from Central Medience, also based in Tokyo. The expected closing of this acquisition is set for September 14, 2026. The objective of this acquisition is to leverage the healthcare content expertise developed by 'Karada ni Ii Koto', thereby enhancing the editorial capabilities of GENOVA's medical media platform, 'Medical DOC'. This strategic move aims to expand their health communication channels beyond digital platforms to include printed materials as part of their outreach.

Purpose of the Acquisition

GENOVA is driven by its mission to connect people with healthcare to foster a healthier society. With a focus on building a 21st-century medical infrastructure, the company works to enhance patient convenience and clinic productivity through clinic automation. Additionally, through 'Medical DOC', they provide reliable medical information to the public. In 2026, GENOVA set out its 'VISION 2026', which aims to bridge the gap between the reality of healthcare and the digital realm. By fostering direct interactions with healthcare facilities and integrating digital initiatives, GENOVA seeks to establish trusted relationships between patients and healthcare providers, thereby reinforcing Japan's medical infrastructure.

The health media business 'Karada ni Ii Koto', renowned for its high-quality health content, has successfully engaged its readers for years through commissioned editing, tie-up advertising, and PR activities. With this acquisition, both media entities will combine their strengths to enhance the planning and editorial capacities for medical and health information. This alignment will strengthen the information dissemination framework as prescribed in 'VISION 2026', broadening access to trustworthy healthcare content for consumers and enhancing the value of GENOVA's medical platform.

Details of the Acquisition

The business of interest revolves around the health media 'Karada ni Ii Koto', focusing on commissioned editing, collaboration ads, and PR services. Here are the key details regarding the acquisition:

• - Sales: 188 million yen (fiscal year ending April 2026)
• - Asset and Liability Transfer: Only assets associated with the business will be transferred, with minimal liabilities.
• - Acquisition Price: 51 million yen (estimated)
• - Payment Method: Cash

Future Synergies and Projections

By combining the knowledge gained from 'Medical DOC' with 'Karada ni Ii Koto', GENOVA aims to offer clearer and more reliable information to the public. The collaboration will enhance commissioned editing, advertising, and PR domains, aiming to develop new content and services that connect businesses and healthcare institutions with the critical information needed by consumers. GENOVA remains committed to improving the quality of healthcare information dissemination and enhancing touchpoints in the medical and health sectors, striving to fulfill its mission of connecting individuals with healthcare for societal health.

Transaction Schedule

• - Board Decision Date: September 11, 2026
• - Contract Signing Date: September 14, 2026
• - Business Start Date: September 14, 2026 (tentative)

Accounting Overview

This acquisition will probably be classified as a 'purchase' under business combination accounting. Details regarding goodwill and other intangible asset considerations are currently under review.

Impact on Business Performance

While the acquisition is expected to have a minor impact on business performance for the fiscal year ending March 2027, GENOVA will promptly update stakeholders on any significant developments regarding impacts as they become apparent.

About GENOVA

GENOVA is dedicated to its mission of connecting individuals with healthcare services to promote a healthy society. The company develops innovative healthcare technology services, addressing contemporary issues like Japan's aging population and the necessity for improved medical accessibility. Through its offerings, GENOVA aims to alleviate uncertainties and frustrations concerning healthcare, striving to provide high-quality medical experiences for patients and users alike.

Company Overview:

• - Location: Shibuya, Tokyo, Japan
• - CEO: Tomoki Hirase
• - Business Areas: Medical platform services / Smart clinic services / Dental distribution services
• - Website: GENOVA
• - Medical Media: Medical DOC

About Central Medience

Founded in 2018, Central Medience emphasizes 'creating innovative medical services' through its mission to enhance health value and societal contributions. By collaborating with medical professionals, the company delivers solutions aimed at optimizing healthcare institutions and innovating services around environmental medical needs.

Company Overview:

• - Location: Konan, Tokyo, Japan
• - CEO: Takutarou Nakagawa
• - Business Scope: Medical institution consulting, pharmaceutical sales, medical supplies distribution, and more.
• - Website: Central Medience

Contact for Inquiries

For more information, please visit the GENOVA contact page: Contact GENOVA